No Data
No Data
Jointown pharmaceutical group (600998.SH): has repurchased 1.07% of its shares accumulated.
Jointown Pharmaceutical Group (600998.SH) announced on August 2nd that as of July 31, 2024, the company has cumulatively repurchased 54.0805 million stocks, accounting for 1.07% of the total share capital. The highest purchase price was 5.18 yuan/stock, the lowest purchase price was 4.42 yuan/stock, and the total amount paid was 258.8364 million yuan (excluding commission and fees).
Jointown Pharmaceutical Group (600998.SH): has repurchased 1.02% of its shares.
Jointown pharmaceutical group (600998.SH) announced on July 26 that as of July 25, 2024, the company has cumulatively repurchased 51.28 million stocks, accounting for 1.02% of the total equity of the company, an increase of 0.65% from the previous disclosure. The highest price purchased was 5.18 yuan/share, and the lowest price was 4.48 yuan/share. The total amount paid was 246.3988 million yuan (excluding commission and fees). The company's stock repurchase progress meets the requirements of relevant laws, regulations, and the company's stock repurchase program.
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Prospects Need A Boost To Lift Shares
Jointown Pharmaceutical Issues 1 Billion Yuan Asset-Backed Bonds
Jointown Pharmaceutical Group (600998.SH) has completed the issuance of asset-backed securities for the second period of 2024.
Jointown Pharmaceutical Group (九州通) announced on July 19th that it has completed the issuance of asset-backed securities for the second phase of 2024, with a total issuance of 1 billion RMB. Chu Chang Investment, a shareholder of the company, subscribed for 50 million RMB of subordinate shares. This transaction constitutes a related-party transaction.
Jointown Pharmaceutical Gets Nod to Issue Shares
No Data